Laura Coates is an NIHR Research Professor whose research focuses on optimal therapeutic strategies in psoriatic arthritis (PsA).  Her PhD focused on the development of the minimal disease activity criteria for PsA and establishment of the TICOPA trial, the first study to show the benefit of treating to target in PsA. Her research is clinical and focuses on psoriatic arthritis and the spondyloarthritides including prediction, prevention and early diagnosis of PsA, development of digital outcome measures, optimal treatment pathways and strategies in PsA.  She is on the steering committee of the British PsA Consortium (BritPACT) and the Group for Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).